Demetri George 4
4 · Blueprint Medicines Corp · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Demetri George
Director
Transactions
- Sale
Common Stock
2021-01-04$112.15/sh−758$85,010→ 3,562 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted on December 18, 2017 and modified on November 7, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.